EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, BG Medicine's Enterprise Value is $0.00 Mil.
BG Medicine's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2015 was $-3.67 Mil. Therefore, BG Medicine's EV-to-FCF for today is 0.00.
The historical rank and industry rank for BG Medicine's EV-to-FCF or its related term are showing as below:
BGMD's EV-to-FCF is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 27.47 * Ranked among companies with meaningful EV-to-FCF only.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for BG Medicine's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, BG Medicine's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BG Medicine's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BG Medicine's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where BG Medicine's EV-to-FCF falls into.
BG Medicine EV-to-FCF Calculation
BG Medicine's EV-to-FCF for today is calculated as:
BG Medicine's current Enterprise Value is $0.00 Mil.
BG Medicine's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.67 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BG Medicine (OTCPK:BGMD) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
BG Medicine's PE Ratio for today is calculated as:
BG Medicine's share price for today is $0.0001.
BG Medicine's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.720.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
BG Medicine EV-to-FCF Related Terms
Thank you for viewing the detailed overview of BG Medicine's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
BG Medicine Inc manufacture and sell diagnostic products that are used to guide the patients suffering from heart failure and related disorders in the United States. It distributes its products such as BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme-linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BGMD has been successfully added to your 